chrX-77600552-T-G
Variant summary
Our verdict is Likely benign. The variant received -6 ACMG points: 0P and 6B. BP4_ModerateBS2
The NM_000489.6(ATRX):c.5579A>C(p.Asn1860Thr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000283 in 1,097,128 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 11 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 15/19 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. N1860S) has been classified as Likely benign.
Frequency
Consequence
NM_000489.6 missense
Scores
Clinical Significance
Conservation
Publications
- alpha thalassemia-X-linked intellectual disability syndromeInheritance: XL Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: G2P, Labcorp Genetics (formerly Invitae), Orphanet, Ambry Genetics
- ATR-X-related syndromeInheritance: XL Classification: DEFINITIVE Submitted by: ClinGen
- intellectual disability-hypotonic facies syndrome, X-linked, 1Inheritance: XL Classification: MODERATE Submitted by: Ambry Genetics
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -6 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_000489.6. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| ATRX | NM_000489.6 | MANE Select | c.5579A>C | p.Asn1860Thr | missense | Exon 23 of 35 | NP_000480.3 | ||
| ATRX | NM_138270.5 | c.5465A>C | p.Asn1822Thr | missense | Exon 22 of 34 | NP_612114.2 |
Ensembl Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| ATRX | ENST00000373344.11 | TSL:1 MANE Select | c.5579A>C | p.Asn1860Thr | missense | Exon 23 of 35 | ENSP00000362441.4 | ||
| ATRX | ENST00000395603.7 | TSL:1 | c.5465A>C | p.Asn1822Thr | missense | Exon 22 of 34 | ENSP00000378967.3 | ||
| ATRX | ENST00000480283.5 | TSL:1 | n.*5207A>C | non_coding_transcript_exon | Exon 24 of 36 | ENSP00000480196.1 |
Frequencies
GnomAD3 genomes Cov.: 22
GnomAD4 exome AF: 0.0000283 AC: 31AN: 1097128Hom.: 0 Cov.: 29 AF XY: 0.0000303 AC XY: 11AN XY: 362770 show subpopulations
Age Distribution
GnomAD4 genome Cov.: 22
ClinVar
Submissions by phenotype
Alpha thalassemia-X-linked intellectual disability syndrome Uncertain:1
This sequence change replaces asparagine, which is neutral and polar, with threonine, which is neutral and polar, at codon 1860 of the ATRX protein (p.Asn1860Thr). This variant is not present in population databases (gnomAD no frequency). This variant has not been reported in the literature in individuals affected with ATRX-related conditions. Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt ATRX protein function with a negative predictive value of 95%. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance.
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at